Zhejiang Tianyu Pharmaceutical Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Zhejiang Tianyu Pharmaceutical Co.,Ltd.

21 YRS

Zhejiang, China

CNY 348.0 Million

53280 m²

Over 1000 people

Main Products: Candesartan Cilexetil / Ezetimibe / Irbesartan / Losartan Potassium / Montelukast Sodium / Olmesartan Medoxomi / Silodosin / Sitagliptin Phosphate Monohydrate / Telmisartan / Valsartan

Zhejiang, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

VERIFIEDMANUFACTURINGCOMPANY

Business Type

Manufacturer

Total Employees

1000+ People

Plant Size

80 Acres

Total Annual Revenue

CNY 1940 Million

Production Experience

21+ Years

MAIN
PRODUCTS

1/3

Candesartan Cilexetil

CAS: 145040-37-5

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

1/3

Ezetimibe

CAS: 163222-33-1

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

1/3

Irbesartan

CAS: 138402-11-6

Packing: 5 KG/BOTTLE

Lead Time: 14-30 days

Inquiry

ABOUT US

Zhejiang Tianyu Pharmaceutical Co.,Ltd.

Zhejiang Tianyu Pharmaceutical Co., Ltd. founded in 2003, is headquartered in Taizhou, Zhejiang. It has six wholly-owned subsidiaries and more than 4800 employees. Tianyu Co., Ltd. is a joint-stock pharmaceutical enterprise specializing in R & D, manufacturing and sales of APIs and advanced pharmaceutical intermediates. It was successfully listed on Shenzhen Stock Exchange on September 19, 2017 (Stock Code: 300702). The company is a national high-tech enterprise, an innovative pilot enterprise in Zhejiang Province and a patent demonstration enterprise in Zhejiang Province. It has established a provincial enterprise research institute, a provincial high-tech enterprise research and development center, a provincial innovation carrier, a provincial enterprise technology center and a provincial postdoctoral research workstation. The company's main products include antihypertensive, hypoglycemic, antithrombotic and antiasthmatic drug raw materials and intermediates. It is one of the world's major manufacturers of cardiovascular raw materials, and its products sell well in markets at home and abroad.